Biolase, Inc. ( BIOL) - Key Metrics
Stock symbol BIOL is outdated, potentially delisted? Maybe it is available on other exchange?
BIOL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.35 | -$0.08 | -$0.02 | -$0.02 |
| 2024Q1 | $0.57 | -$0.36 | -$0.33 | -$0.33 |
| 2023Q4 | $4.45 | -$1.76 | -$0.75 | -$0.81 |
| 2023Q3 | $9.26 | -$3.89 | -$2.20 | -$2.35 |
| 2023Q2 | $26.21 | -$8.93 | -$6.54 | -$7.19 |
BIOL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -0.32 |
| 2024Q1 | ? | -0.13 |
| 2023Q4 | ? | -0.16 |
| 2023Q3 | ? | -0.12 |
| 2023Q2 | ? | -0.20 |
BIOL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q2 | -21.14% | ? |
| 2024Q1 | -171.48% | ? |
| 2023Q4 | -72.70% | ? |
| 2023Q3 | -126.31% | ? |
| 2023Q2 | -102.73% | ? |
BIOL
Price: $0.02
52 week price:
Payout Ratio Range:
Earnings Per Share: 16.18 USD
P/E Ratio: 0.00
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 574700
Ebitda: -14.7 millionMarket Capitalization: 453804